Moreover, recent findings have linked a number of genetic mutations in thyroid cancer that are associated with the polarization of TAMs, for instance, mutations in the BRAF gene have been shown to result in the conversion of TAMs to the M2 phenotype [194], and targeted therapies can be much better exploited with the benefit of this gene. Here, BRAF is linked to thyroid cancer.